{"id":79206,"date":"2026-09-07T12:46:44","date_gmt":"2026-09-07T04:46:44","guid":{"rendered":"https:\/\/flcube.com\/?p=79206"},"modified":"2026-09-07T12:46:45","modified_gmt":"2026-09-07T04:46:45","slug":"hepabio-therapeutics-raises-series-a-strategic-funding-from-triapex-to-advance-organoid-technology-and-next-generation-drug-rd-systems","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=79206","title":{"rendered":"HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&amp;D Systems"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>HepaBio Therapeutics<\/strong> announced that it has raised tens of millions of RMB in Series A strategic funding from <strong>TriApex<\/strong>. The two parties will engage in deep collaboration focused on new approach methodologies (NAMs), <strong>organoid<\/strong> technology platforms, and non\u2011clinical evaluation systems for innovative drugs, jointly promoting the construction of next\u2011generation drug R&amp;D technology systems.<\/p>\n\n\n\n<h2 id=\"h-financing-milestone\" class=\"wp-block-heading\">Financing Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Field<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td>Company<\/td><td><strong>HepaBio Therapeutics<\/strong><\/td><\/tr><tr><td>Investor<\/td><td><strong>TriApex<\/strong> (strategic investor)<\/td><\/tr><tr><td>Round<\/td><td>Series A strategic funding<\/td><\/tr><tr><td>Amount<\/td><td>Tens of millions of RMB<\/td><\/tr><tr><td>Date<\/td><td>28 Aug 2026<\/td><\/tr><tr><td>Use of Proceeds<\/td><td>Advancing <strong>organoid<\/strong> technology innovation, expanding disease models and drug R&amp;D application scenarios<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-collaboration-framework-amp-technology-profile\" class=\"wp-block-heading\">Collaboration Framework &amp; Technology Profile<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>New Approach Methodologies (NAMs):<\/strong> Joint focus on next\u2011generation, human\u2011relevant testing methodologies for drug evaluation.<\/li>\n\n\n\n<li><strong>Organoid Technology Platforms:<\/strong> <strong>HepaBio Therapeutics<\/strong> will continue to advance <strong>organoid<\/strong> technology innovation as the core of the collaboration.<\/li>\n\n\n\n<li><strong>Non\u2011Clinical Evaluation Systems:<\/strong> Development of evaluation systems for innovative drugs, spanning earlier and more predictive preclinical assessment.<\/li>\n\n\n\n<li><strong>Strategic Partnership:<\/strong> Beyond capital, <strong>TriApex<\/strong> and <strong>HepaBio Therapeutics<\/strong> will collaborate deeply to jointly build next\u2011generation drug R&amp;D technology systems.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-growth-strategy-application-expansion\" class=\"wp-block-heading\">Growth Strategy \u2013 Application Expansion<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Focus Area<\/th><th>Direction<\/th><\/tr><\/thead><tbody><tr><td>Organoid Technology Innovation<\/td><td>Continued advancement of platform capabilities<\/td><\/tr><tr><td>Disease Models<\/td><td>Expansion of <strong>organoid<\/strong>\u2011based disease model coverage<\/td><\/tr><tr><td>Drug R&amp;D Scenarios<\/td><td>Broadening application scenarios across drug discovery and development<\/td><\/tr><tr><td>Industry Collaboration<\/td><td>Partnering to explore more precise, efficient, and human\u2011relevant drug discovery pathways<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Moving forward, <strong>HepaBio Therapeutics<\/strong> will continue to advance <strong>organoid<\/strong> technology innovation, expand disease models and drug R&amp;D application scenarios, and collaborate with industry partners to explore more precise, efficient, and human\u2011relevant drug discovery and development pathways \u2014 positioning the company at the center of the shift toward NAMs\u2011based, human\u2011relevant preclinical models.<\/p>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>NAMs Momentum:<\/strong> The Series A investment from <strong>TriApex<\/strong> underscores growing industry demand for new approach methodologies and <strong>organoid<\/strong>\u2011based non\u2011clinical evaluation as alternatives and complements to animal testing.<\/li>\n\n\n\n<li><strong>Strategic Alignment:<\/strong> The funding is paired with deep operational collaboration, aligning capital, technology, and commercial ecosystems around next\u2011generation drug R&amp;D systems.<\/li>\n\n\n\n<li><strong>Platform Scalability:<\/strong> Expansion of disease models and application scenarios broadens <strong>HepaBio Therapeutics<\/strong>&#8216; addressable markets across innovative drug development.<\/li>\n\n\n\n<li><strong>Human\u2011Relevance Advantage:<\/strong> More precise, efficient, and human\u2011relevant drug discovery pathways address a persistent bottleneck in translational success rates for innovative drugs.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong> \u2014 This brief contains forward\u2011looking statements regarding <strong>HepaBio Therapeutics<\/strong>&#8216; Series A strategic funding from <strong>TriApex<\/strong> and its future development of <strong>organoid<\/strong> technology platforms, new approach methodologies, and non\u2011clinical evaluation systems for innovative drugs. Such statements are based on current expectations and are subject to risks and uncertainties, including technology development, collaboration execution, and commercialization risks. Actual results may differ materially. Nothing herein constitutes investment advice or an offer to buy or sell any securities.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>HepaBio Therapeutics announced that it has raised tens of millions of RMB in Series A&#8230;<\/p>\n","protected":false},"author":1,"featured_media":79210,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10,4908],"tags":[20,4930,4801],"class_list":["post-79206","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-pic","tag-finance","tag-hepabio-therapeutics","tag-triapex-laboratories"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&amp;D Systems - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"HepaBio Therapeutics announced that it has raised tens of millions of RMB in Series A strategic funding from TriApex. The two parties will engage in deep collaboration focused on new approach methodologies (NAMs), organoid technology platforms, and non\u2011clinical evaluation systems for innovative drugs, jointly promoting the construction of next\u2011generation drug R&amp;D technology systems.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=79206\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&amp;D Systems\" \/>\n<meta property=\"og:description\" content=\"HepaBio Therapeutics announced that it has raised tens of millions of RMB in Series A strategic funding from TriApex. The two parties will engage in deep collaboration focused on new approach methodologies (NAMs), organoid technology platforms, and non\u2011clinical evaluation systems for innovative drugs, jointly promoting the construction of next\u2011generation drug R&amp;D technology systems.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=79206\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-07T04:46:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-07T04:46:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0704.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=79206#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=79206\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&amp;D Systems\",\"datePublished\":\"2026-09-07T04:46:44+00:00\",\"dateModified\":\"2026-09-07T04:46:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=79206\"},\"wordCount\":484,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=79206#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/0704.webp\",\"keywords\":[\"Finance\",\"HepaBio Therapeutics\",\"TriApex Laboratories\"],\"articleSection\":[\"Company\",\"Deals\",\"PIC\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=79206#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=79206\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=79206\",\"name\":\"HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&amp;D Systems - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=79206#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=79206#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/0704.webp\",\"datePublished\":\"2026-09-07T04:46:44+00:00\",\"dateModified\":\"2026-09-07T04:46:45+00:00\",\"description\":\"HepaBio Therapeutics announced that it has raised tens of millions of RMB in Series A strategic funding from TriApex. The two parties will engage in deep collaboration focused on new approach methodologies (NAMs), organoid technology platforms, and non\u2011clinical evaluation systems for innovative drugs, jointly promoting the construction of next\u2011generation drug R&D technology systems.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=79206#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=79206\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=79206#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/0704.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/0704.webp\",\"width\":1080,\"height\":608,\"caption\":\"HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&D Systems\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=79206#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&amp;D Systems\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&amp;D Systems - Insight, China&#039;s Pharmaceutical Industry","description":"HepaBio Therapeutics announced that it has raised tens of millions of RMB in Series A strategic funding from TriApex. The two parties will engage in deep collaboration focused on new approach methodologies (NAMs), organoid technology platforms, and non\u2011clinical evaluation systems for innovative drugs, jointly promoting the construction of next\u2011generation drug R&D technology systems.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=79206","og_locale":"en_US","og_type":"article","og_title":"HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&amp;D Systems","og_description":"HepaBio Therapeutics announced that it has raised tens of millions of RMB in Series A strategic funding from TriApex. The two parties will engage in deep collaboration focused on new approach methodologies (NAMs), organoid technology platforms, and non\u2011clinical evaluation systems for innovative drugs, jointly promoting the construction of next\u2011generation drug R&D technology systems.","og_url":"https:\/\/flcube.com\/?p=79206","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-09-07T04:46:44+00:00","article_modified_time":"2026-09-07T04:46:45+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0704.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=79206#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=79206"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&amp;D Systems","datePublished":"2026-09-07T04:46:44+00:00","dateModified":"2026-09-07T04:46:45+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=79206"},"wordCount":484,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=79206#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0704.webp","keywords":["Finance","HepaBio Therapeutics","TriApex Laboratories"],"articleSection":["Company","Deals","PIC"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=79206#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=79206","url":"https:\/\/flcube.com\/?p=79206","name":"HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&amp;D Systems - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=79206#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=79206#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0704.webp","datePublished":"2026-09-07T04:46:44+00:00","dateModified":"2026-09-07T04:46:45+00:00","description":"HepaBio Therapeutics announced that it has raised tens of millions of RMB in Series A strategic funding from TriApex. The two parties will engage in deep collaboration focused on new approach methodologies (NAMs), organoid technology platforms, and non\u2011clinical evaluation systems for innovative drugs, jointly promoting the construction of next\u2011generation drug R&D technology systems.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=79206#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=79206"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=79206#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0704.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0704.webp","width":1080,"height":608,"caption":"HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&D Systems"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=79206#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"HepaBio Therapeutics Raises Series A Strategic Funding From TriApex to Advance Organoid Technology and Next\u2011Generation Drug R&amp;D Systems"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0704.webp","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/79206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=79206"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/79206\/revisions"}],"predecessor-version":[{"id":79211,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/79206\/revisions\/79211"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/79210"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=79206"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=79206"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=79206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}